Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (381-390 of 706) with videos related to

Pageof 71
Sort By:
Heart, Lung & Circulation|September 24, 2013
Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western AustraliaDamon A Bell, Jacquie Garton-Smith, Alistair Vickery, et al.
The Australian and New Zealand Journal of Psychiatry|July 26, 2015
Common familial risk factors for schizophrenia and diabetes mellitusDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) ConcentrationLouis Ma, Dick C Chan, Esther M M Ooi, et al.
Lancet (London, England)|November 22, 2024
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)Timo E Strandberg, Petri T Kovanen, Donald M Lloyd-Jones, et al.
Heart, Lung & Circulation|December 3, 2014
Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methodsAndrew B Kirke, Rita A Barbour, Sally Burrows, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Diabetes|July 30, 2002
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemiaDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Journal of Clinical Lipidology|September 15, 2020
The economic impact of familial hypercholesterolemia on productivityZanfina Ademi, Clara Marquina, Ella Zomer, et al.
Clinical Endocrinology|November 23, 2007
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese menDick C Chan, Gerald F Watts, Jian Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Pageof 71

Showing results (381-390 of 706) with videos related to

Sort By:
Pageof 71
Heart, Lung & Circulation|September 24, 2013
Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western AustraliaDamon A Bell, Jacquie Garton-Smith, Alistair Vickery, et al.
The Australian and New Zealand Journal of Psychiatry|July 26, 2015
Common familial risk factors for schizophrenia and diabetes mellitusDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) ConcentrationLouis Ma, Dick C Chan, Esther M M Ooi, et al.
Lancet (London, England)|November 22, 2024
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)Timo E Strandberg, Petri T Kovanen, Donald M Lloyd-Jones, et al.
Heart, Lung & Circulation|December 3, 2014
Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methodsAndrew B Kirke, Rita A Barbour, Sally Burrows, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Diabetes|July 30, 2002
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemiaDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Journal of Clinical Lipidology|September 15, 2020
The economic impact of familial hypercholesterolemia on productivityZanfina Ademi, Clara Marquina, Ella Zomer, et al.
Clinical Endocrinology|November 23, 2007
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese menDick C Chan, Gerald F Watts, Jian Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Pageof 71